Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Akerna Corp.

Akerna Corp. (KERN) Stock Overview

Explore Akerna Corp.’s financial performance, market position, analyst ratings, and future outlook.

KERN●NASDAQ
HealthcareMedical - Healthcare Information Services
$0.31
$0.08(36.94%)
U.S. Market opens in 63h 27m

Akerna Corp. (KERN)

Meyka AI Score

Z

Key Financials

Market Cap162.3K
P/E Ratio-2.20
EPS (TTM)$-44.60
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

KERN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Akerna Corp. (NASDAQ: KERN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Akerna Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of KERN on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Akerna Corp.'s NASDAQ-traded stock include a P/E ratio of -2.20 and a market capitalization of 162.3K. Combined with our AI analysis, these give both institutional and retail investors a clear view of KERN on the NASDAQ.

Price Performance (NASDAQ: KERN)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-95.69%
6-Month Change
-94.97%
Year-to-Date (YTD) Change
-95.93%
1-Year Change
-98.22%
3-Year Change
-99.99%
5-Year Change
-99.99%
All-Time (Max) Change
-99.99%

Contact Information

https://www.akerna.com
888 932 6537
1550 Larimer Street, Denver, CO, 80202

Company Facts

1,120 Employees
IPO DateFeb 26, 2018
CountryUS

Frequently Asked Questions